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All physiological functions decline with age, but which changes are primary and which are secondary is not
always clear. Liu et al. (2013), examining functional changes in the muscles and motor neurons of C. elegans,
suggest that when it comes to locomotion, it is the nervous system that shows earlier age-related deteriora-
tion.An evident feature of human aging is the
coexistence of multiple forms of age-
related functional deterioration, which
individually and collectively become ap-
parent in the later stages of the lifespan.
Indeed, when we say sometimes that a
person has died of old age, we mean that
if it had not been this particular cause
today, itmight easily havebeen something
else tomorrow. For example, a recent
study of a representative cohort of 85
year olds found that three-quarters of
them exhibited four or more different
age-related conditions (Collerton et al.,
2009). The relationship between intrinsic
aging and the multiplicity of diseases and
disorders that show marked increases in
prevalence with age lies at the heart of
the biomedical efforts to understand how
aging science might be applied to
enhance the quality of later life. To make
such a goal attainable, the field needs to
uncover the complexity of age-related
functional decline. This will involve discov-
ering: (i) what explains the similarities (and
differences) in the timing of failure of the
different organ systems within the body;
(ii) which of the underlying molecular
mechanisms of cellular aging contribute
most to the functional declines; and (iii) to
what extent the driving mechanisms may
differ from one organ system to another.
Herein lies the challenge of a systems un-
derstanding of the biology of aging (Kirk-
wood 2008). For a long time, something
of a gulf existed between human and
mammalian model systems, where or-
gan-basedpathobiology iswell advanced,
and research using invertebrate models
(notably fruit flies and nematode worms),
where genetic studies of longevity were
highly amenable but detailed pathology
was absent. In effect, answers were lack-ing to the following question: what does
the aged worm or fly die from? Over the
last decade, studies of age-related patho-
logical changes in invertebrates have
begun to bridge this gap (Herndon et al.,
2002, Huang et al., 2004, Hsu et al.,
2009, Fontana et al., 2010, Nishimura
et al., 2011), and a significant further step
is taken by the report in this issue of Cell
Metabolism from Liu et al. (2013), who
have probed the intricacies of functional
aging in Caenorhabditis elegans. They
show that motor neurons exhibit a pro-
gressive functional declinebeginning early
in life, whereas muscles show no detect-
able functional deficit until mid to late life.
The most obvious manifestation of
senescence in the aging worm is that it
moves ever more slowly and eventually
stops moving altogether. But movement
is a complex phenotype requiring not
only the action of the muscles, but also
their activation by motor neurons. So,
does locomotory senescence derive pri-
marily from deterioration in muscles or in
the nervous system? Previous work sug-
gested that body wall muscles underwent
primary functional aging, while the ner-
vous system appeared to be relatively
spared (Herndon et al., 2002). However,
these and other observations relied
largely on analyzing morphology, which
does not necessarily reveal the underlying
functionality of the tissues. Liu et al. (2013)
now perform a functional analysis of the
aging nervous system and muscles in
C. elegans across the lifespan using
patch-clamp recordings. They confirm
that the aged worm does indeed turn
more slowly, the decline in speed begin-
ning around day 5 and dropping steeply
thereafter. This early slowing precedes
the earliest signs of morphological deteri-Cell Metabolism 18, Soration in muscles, which do not appear
until midlife (around day 10). Using
electrophysiological recordings, they me-
asured the frequency of spontaneous
neurotransmitter release from presynap-
tic motor neurons, which reflects the ac-
tivity of the motor nervous system in the
body of the worm. The earliness of the
observed decline led the authors to infer
that it is aging in the nervous system that
largely drives the decay in locomotory
activity. Furthermore, in contrast to the
early decline in the frequency of sponta-
neous neurotransmitter release, no alter-
ation in the amplitude of the postsynaptic
currents associated with such release
occurs until midlife. The authors interpret
this result as evidence for a lack of signif-
icant decline in the function of body wall
muscle receptors. However, this observa-
tion does not alone preclude the possibil-
ity that muscle cells might nevertheless
be deficient in initiating contraction in
response to activation of muscle recep-
tors. To exclude this possibility, the au-
thors used the agonist levamisole, which
acts upon the excitatory nicotinic acetyl-
choline receptors, to induce contraction.
Using a real-time, automated tracking
system, they found no deficit in contrac-
tion (rate or extent) before day 9, although
some deterioration did appear by day 15.
Can we therefore conclude that, as far
as worm locomotion is concerned, it is
the nervous system that ages first,
with the muscles deteriorating later?
Although the results are an important
advance, such a conclusion is premature.
The question of primary causality will
need further analysis. Liu et al. (2013)
have progressed beyond morphological
analysis to functional measurement, but
we also need to understand the moleculareptember 3, 2013 ª2013 Elsevier Inc. 303
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Previewsevents that underlie these functional
changes before we can truly discern
what is primary and what is secondary.
The ultimate driving force of age-related
deterioration is the accumulation of de-
fects in the macromolecules and organ-
elles that make up the relevant cells.
Which types of faults contribute most to
functional declines of the cells (and there-
after the tissues) and how the kinetics of
such declines plays out across the life
course are chapters yet to be written.304 Cell Metabolism 18, September 3, 2013 ªREFERENCES
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Leptin mimics many of the antidiabetic actions of insulin in insulin-deficient diabetes, but the mechanism is
controversial. Fujikawa et al. (2013) reveal that leptin receptors in g-aminobutyric acid (GABA)-ergic and
pro-opiomelanocortin (POMC) neurons in the central nervous system are sufficient to mediate the lifesaving
and antidiabetic actions of leptin in insulin-deficient mice.The discovery of insulin in 1921–1922 and
its profound, lifesaving effect on people
with type 1 diabetes (T1DM) was one of
the miracles of modern medicine. Normal
glucose control without insulin seemed
impossible. Yet, recent studies demon-
strate that the adipocyte-secreted,
anorexigenic hormone, leptin, also has
potent antidiabetic actions in insulin-defi-
cient diabetes. In this issue, Fujikawa
et al. elucidate the underlying mecha-
nisms by identifying specific neuronal
subtypes that can mediate the glucose-
lowering effects of leptin in the absence
of insulin (Fujikawa et al., 2013).
Although insulin therapy is effective for
T1DM, diabetic complications including
retinopathy, nephropathy, cardiovascular
disease, and lower hindlimb amputation
are still major problems. Insulin therapy
lacks the precision necessary to mimic
the finely tuned dynamics of insulin secre-
tion from pancreatic b cells. Intensive
insulin treatment reduces the incidenceand progression of diabetic complica-
tions but increases the frequency of
severe hypoglycemia and may contribute
to increased adiposity, hepatic steatosis,
and adverse plasma lipoprotein profiles
in T1DM. Leptin could be a potential
adjunctive therapy for T1DM because of
its beneficial effects on glucose meta-
bolism and its antisteatotic and appetite-
suppressive effects (Wang et al., 2010;
Morton and Schwartz, 2011). Leptin
increases glucose utilization in peripheral
tissues, suppresses hepatic glucose pro-
duction, and reverses hyperglucagone-
mia in insulin-deficient rodents (German
et al., 2011; Wang et al., 2010) (Figure 1).
These effects are independent of leptin’s
anorexic effect and appear to be medi-
ated through the hypothalamus, although
the neuronal circuits are unknown.
Fujikawa et al. used two complemen-
tary models of insulin-deficient diabetes
induced by (1) the pancreatic b cell toxin
streptozotocin or (2) diphtheria toxintreatment in mice expressing the diph-
theria-toxin receptor driven by a rat insulin
promoter (RIP), which ablated nearly all
pancreatic b cells. To determine which
neuronal population(s) mediate the
effects of intracerebroventricular (i.c.v.)
leptin—leptin administered directly into
the brain ventricles—in insulin-deficient
mice, the authors deleted or re-expressed
the leptin receptor (LEPR) in a neuron
type-specific manner.
LEPR ablation selectively in POMC
neurons marginally blunted the hypergly-
cemia-lowering action of i.c.v. leptin in
insulin-deficient mice, and LEPR ablation
in steroidogenic factor 1 (SF1) neurons
(enriched in the ventromedial hypothala-
mus, VMH) had no effect. Furthermore,
LEPR re-expression in POMC neurons
alone in insulin-deficient mice lacking
LEPR in all other tissues failed to improve
hyperglycemia or survival in response to
i.c.v. leptin. In contrast, LEPR re-expres-
sion selectively in GABAergic neurons
